[RGLS] QoQ Quarter Result on 30-Sep-2016 [#Q3]

Stock
[RGLS] Regulus Therapeutics Inc.
Announcement Date
01-Nov-2016
Financial Year
2016
Quarter
30-Sep-2016 [#Q3]
Profit Trend
QoQ- 7.45%
YoY- -50.15%
Quarter Report
RGLS's Result
RGLS's Financial Summary
View:
Show?
Quarter Result
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
Revenue 18 18 18 204 483 489 10,860 -98.60%
PBT -21,736 -20,025 -20,015 -19,515 -21,098 -21,212 -7,222 108.59%
Tax -128 -4 5 4 -8 -5 4 -
NP -21,608 -20,021 -20,020 -19,519 -21,090 -21,207 -7,226 107.69%
Tax Rate - - - - - - - -
Total Cost 21,626 20,039 20,038 19,723 21,573 21,696 18,086 12.66%
Ratio Analysis
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
NP Margin -120,044.44 -111,227.78 -111,222.22 -9,568.14 -4,366.46 -4,336.81 -66.54 14787.56%
Per Share
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
EPS -48.76 -45.34 -45.39 -44.33 -47.95 -48.28 -16.52 105.89%
EPS Diluted -48.76 -45.34 -45.39 -44.33 -47.95 -48.28 -16.52 105.89%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.